Efficacy of methylene blue for on vasoplegic syndrome
Reviews in Clinical Medicine [RCM]. 2016; 3 (2): 69-72
em Inglês
| IMEMR
| ID: emr-184821
ABSTRACT
Introduction:
Administration of methylene blue has been proposed as a therapeutic strategy in the treatment of vasopelgic shock following cardiac surgery. Major aims of this systematic review were to evaluate the effect of methylene blue on mortality rate, duration of vasoplegic syndrome, and further complications of patients with vasoplegic syndrome following cardiac surgery
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Tipo de estudo:
Ensaio Clínico Controlado
/
Revisões Sistemáticas Avaliadas
Idioma:
Inglês
Revista:
Rev. Clin. Med.
Ano de publicação:
2016
Similares
MEDLINE
...
LILACS
LIS